INVO Bioscience
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. INVO Bioscience's past years’ income statements indicate that its last revenue has increased compared to the previous period by 267% to $3,020,575. The net income raised on -$8,034,612 and profit margin reached -266%. Total operating expenses were $7,853,293.

Profit Margin

INVO Bioscience, Inc. (NASDAQ:INVO): Profit margin
2014 16.58K -1.73M -10444.13%
2015 11.68K -4.95M -42426.61%
2016 50.90K -2.12M -4173.3%
2017 282.14K -702.16K -248.87%
2018 494.37K -3.07M -622.22%
2019 1.48M -2.16M -146.43%
2020 1.03M -8.34M -804.73%
2021 4.16M -6.65M -159.97%
2022 822.19K -10.89M -1324.81%
2023 3.02M -8.03M -266%

INVO Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
3.02M822.19K4.16M1.03M1.48M494.37K282.14K50.90K11.68K16.58K
Cost of revenue
1.93M331.52K145.05K88.76K139.67K90.36K51.95K15.09K7.81K7.68K
Gross profit
1.08M490.67K4.01M948.52K1.34M404.00K230.19K35.80K3.87K8.90K
Operating exp.
Research and development
165.94K544.04K216.43K398.42K000000
Selling and marketing
0000000000
Total operating expenses
7.85M11.11M9.23M6.46M3.12M3.03M870.61K2.14M598.95K1.68M
Operating income
-6.76M-10.62M-5.21M-5.51M-1.78M-2.63M-640.42K-2.11M-595.07K-1.68M
Other income (expenses), net
-1.23M-263.15K-1.43M-2.83M-379.01K-442.03K-61.74K-13.83K-4.36M-51.89K
Income before tax
-8.00M-10.88M-6.65M-8.34M-2.16M-3.07M-702.16K-2.12M-4.95M-1.73M
Income tax expense
27.78K2.87K4.76K36433020.87K032.01K0
Net income
-8.03M-10.89M-6.65M-8.34M-2.16M-3.07M-702.16K-2.12M-4.95M-1.73M
Earnings per share
Basic EPS
-5.13-17.97-12.52-30.41-8.93-12.76-3.16-0.48-23.15-13.35
Diluted EPS
-5.13-17.97-12.52-30.41-8.93-12.76-3.16-0.48-23.15-13.35
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source